California Cancer Reporting System Standards, Volume III
CS
California Hospital Transmit
Eureka Tumor Level
Eureka Admission Level
Behavior Code ICD-0-3 [NAACCR #523]
CS Site Specific Factor 1 [NAACCR #2880]
CS Site Specific Factor 25 [NAACCR #2879]
Histologic Type ICD-0-3 [NAACCR #522]
Primary Site [NAACCR #400]
RX Summ--Surg Prim Site [NAACCR #1290]
RX Summ--DX/Stg Proc [NAACCR #1350]
N/A
IF 491: Conflict among schemas: CS Site Specific Factor 2 [value], RX Summ--Surg Prim Site [value]
This edit verifies that for cases coded using the Pleura schema, if CS Site-Specific Factor 2 (Histologic Subtype) indicates that there was not pathologic examination, then RX Summ--Surg Prim Site does not indicate that a specimen was sent to pathology.
This edit first determines the CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
This edit is skipped if any of the following conditions are true:
CS Site-Specific Factor 2 is blank or 988
RX Summ--Surg prim Site is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
CS schema is invalid
The logic is as follows:
If CS schema is Pleura:
If CS Site-Specific Factor 2 = 998 (No histologic examination), then RX Summ--Surg Prim Site must not be 20-89.
In the SEER*Edits software, the title of this edit is: IF371. |
|
07/27/11 |
This new edit was created to comply with NAACCR 12.1.A. |
03/02/12 |
Per v12.1B: Deleted for NAACCR v12.1B metafile because edit uses CS over-rides that should not be used until release of 2012 NAACCR v12.2 metafile. Per NAACCR v12.2: Re-added to NAACCR v12.2 metafile, but the over-ride was removed from the edit. |
04/2014 |
Per NAACCR v14, Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll.” Corrected edit specifications to match edit logic. |